Breast surgeon's survey: No consensus for surgical treatment of pleomorphic lobular carcinoma in situ

Breast Journal

Volumn 19, Issue 1, 2013, Pages 116-118

  Blair, Sarah L ^a   Emerson, Derek K ^a   Kulkarni, Swati ^b   Hwang, E Shelley ^c   Malcarne, Vanessa ^d   Ollila, David W ^e  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CHICAGO   (United States)

^c DUKE UNIVERSITY   (United States)

^d SAN DIEGO STATE UNIVERSITY   (United States)

^e UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR; MYC PROTEIN; PROGESTERONE RECEPTOR;

BREAST CARCINOMA; CANCER ADJUVANT THERAPY; CANCER RADIOTHERAPY; CARCINOMA IN SITU; CHEMOPROPHYLAXIS; CONSENSUS; FOLLOW UP; GENE AMPLIFICATION; HISTOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; LETTER; MASTECTOMY; OUTCOME ASSESSMENT; PLEOMORPHIC LOBULAR CARCINOMA IN SITU; PROSPECTIVE STUDY; PROTEIN EXPRESSION; RANDOMIZED CONTROLLED TRIAL (TOPIC); RETROSPECTIVE STUDY; TUMOR RECURRENCE;

BREAST NEOPLASMS; CARCINOMA IN SITU; CARCINOMA, LOBULAR; FEMALE; HUMANS; MASTECTOMY, SEGMENTAL; NEOPLASM, RESIDUAL; PHYSICIAN'S PRACTICE PATTERNS; QUESTIONNAIRES;

EID: 84872268962     PISSN: 1075122X     EISSN: 15244741     Source Type: Journal    
DOI: 10.1111/tbj.12062     Document Type: Letter

References (18)

1. Ewing J,. Neoplastic Diseases: A Textbook on Tumors. Philadelphia, PA: WB Saunders, 1919.
2. Foote FW, Stewart FW,. Lobular carcinoma in situ: a rare form of mammary cancer. Am J Pathol 1941; 17: 491-4963.
3. Haagensen CD, Lane N, Lattes R, Bodian C,. Lobular neoplasia (so-called lobular carcinoma in situ) of the breast. Cancer 1978; 42: 737-69.
4. Ciocca RM, Li T, Freedman GM, Morrow M,. Presence of lobular carcinoma in situ does not increase local recurrence in patients treated with breast-conserving therapy. Ann Surg Oncol 2008; 15: 2263-71.
5. Chuba PJ, Hamre MR, Yap J, et al,. Bilateral risk for subsequent breast cancer after lobular carcinoma-in-situ: analysis of surveillance, epidemiology, and end results data. J Clin Oncol 2005; 23: 5534-41.
6. Sneige N, Wang J, Baker BA, Krishnamurthy S, Middleton LP,. Clinical, histopathologic, and biologic features of pleomorphic lobular (ductal-lobular) carcinoma in situ of the breast: a report of 24 cases. Mod Pathol 2002; 15: 1044-50.
7. Reis-Filho JS, Simpson PT, Jones C, et al,. Pleomorphic lobular carcinoma of the breast: role of comprehensive molecular pathology in characterization of an entity. J Pathol 2005; 207: 1-13.
8. Chivukula M, Haynik DM, Brufsky A, Carter G, Dabbs DJ,. Pleomorphic lobular carcinoma in situ (PLCIS) on breast core needle biopsies: clinical significance and immunoprofile. Am J Surg Pathol 2008; 32: 1721-6.
9. Blair SL, Thompson K, Rococco J, Malcarne V, Beitsch PD, Ollila DW,. Attaining negative margins in breast-conservation operations: is there a consensus among breast surgeons? J Am Coll Surg 2009; 209: 608-13.
10. Bentz JS, Yassa N, Clayton F,. Pleomorphic lobular carcinoma of the breast: clinicopathologic features of 12 cases. Mod Pathol 1998; 11: 814-22.
11. Fadare O,. Pleomorphic lobular carcinoma in situ of the breast composed almost entirely of signet ring cells. Pathol Int 2006; 56: 683-7.
12. Middleton LP, Palacios DM, Bryant BR, Krebs P, Otis CN, Merino MJ,. Pleomorphic lobular carcinoma: morphology, immunohistochemistry, and molecular analysis. Am J Surg Pathol 2000; 24: 1650-6.
13. Page DL, Kidd TE, Jr,., Dupont WD, Simpson JF, Rogers LW,. Lobular neoplasia of the breast: higher risk for subsequent invasive cancer predicted by more extensive disease. Hum Pathol 1991; 22: 1232-9.
14. Wahed A, Connelly J, Reese T,. E-cadherin expression in pleomorphic lobular carcinoma: an aid to differentiation from ductal carcinoma. Ann Diagn Pathol 2002; 6: 349-51.
15. Fadare O, Dadmanesh F, Alvarado-Cabrero I, et al,. Lobular intraepithelial neoplasia [lobular carcinoma in situ] with comedo-type necrosis: a clinicopathologic study of 18 cases. Am J Surg Pathol 2006; 30: 1445-53.
16. Lavoue V, Graesslin O, Classe JM, Fondrinier E, Angibeau H, Leveque J,. Management of lobular neoplasia diagnosed by core needle biopsy: study of 52 biopsies with follow-up surgical excision. Breast 2007; 16: 533-9.
17. Chen YY, Hwang ES, Roy R, et al,. Genetic and phenotypic characteristics of pleomorphic lobular carcinoma in situ of the breast. Am J Surg Pathol 2009; 33: 1683-94.
18. Downs-Kelly E, Bell D, Perkins GH, Sneige N, Middleton LP,. Clinical implications of margin involvement by pleomorphic lobular carcinoma in situ. Arch Pathol Lab Med 2011; 135: 737-43.